OncoCyte Corp·4/A

Apr 30, 8:08 PM ET

Levine Mitchell S 4/A

4/A · OncoCyte Corp · Filed Apr 30, 2020

Insider Transaction Report

Form 4/AAmended
Period: 2020-04-28
Levine Mitchell S
Chief Financial Officer
Transactions
  • Award

    Restricted Stock Units

    2020-04-28+20,00020,000 total
    Common Stock (20,000 underlying)
Footnotes (2)
  • [F1]Grant of restricted stock units under the OncoCyte 2018 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Common Stock.
  • [F2]The restricted stock units shall vest upon the completion of one year of continuous service from the date of grant.

Documents

1 file
  • 4
    ownership.xml